Clinical Trial of Miltefosine to Treat Mucosal Leishmaniasis

NCT01377974 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Leishmaniasis
Leishmaniasis, Mucocutaneous

Interventions

DRUG: Miltefosine
DRUG: Standard Treatment Meglumine antimoniate

Sponsor

Brasilia University Hospital